Blog

What a DEXA Scan Shows That Your Scale Can't

By Sagan Schultz, MD

Overview

A DEXA scan is a low-dose X-ray that sorts your body into fat, muscle, and bone, and shows where each one sits. You lie on a table, fully clothed, for a few minutes while the scanner passes over you.[1]

DEXA scans have gone mainstream. One provider now scans more than 1,000 people a day, and health coaching memberships have started to include them.[2] That's a good thing.

A scale tells you what you weigh, and BMI compares that weight to your height. Neither can tell muscle from fat or show where your fat is stored. A DEXA scan can. The most useful thing it shows is visceral fat, the fat packed around your organs that's most closely tied to diabetes and heart disease.[3] You can have a normal BMI and still carry too much of it. In SONATA's analysis of national survey data, about 1 in 12 adults aged 20 to 59 with a normal BMI did.[4]

Visceral fat also drops with exercise even when your weight doesn't change.[5] In your 30s and 40s, that makes a scan one of the clearest ways to see where you stand and whether what you're doing is working.

Key takeaways

QuestionAnswer
What does a DEXA scan measure?Fat, muscle, and bone, where each one sits, and visceral fat, at a very low radiation dose.[6]
Why does visceral fat matter?It's the fat most closely tied to diabetes and heart disease, and BMI can't see it. About 1 in 12 adults with a normal BMI have too much.[3, 4]
What's a good visceral fat number?There's no official cutoff. At SONATA, we aim for under 500 grams on a GE scanner, below the levels linked to higher risk.[7, 8]
What lowers visceral fat?Exercise, even when your weight doesn't change. Ab exercises alone don't.[5, 9]
Should I get a DEXA scan on a GLP-1?Yes. Some of the weight you lose is lean mass, and a scan shows how much.[10]
How often should I get scanned?On the same machine, under the same conditions, with enough time between scans for real change to show.[6, 11]

What does a DEXA scan measure?

DEXA stands for dual-energy X-ray absorptiometry. The scanner passes X-rays at two energy levels over your body, and bone, fat, and lean tissue absorb them differently. Software uses that difference to work out how much of each is in every part of the image. A whole-body scan uses about as much radiation as you get from nature in a single day.[6]

The report shows your fat, lean mass, and bone for your whole body and for your arms, legs, and trunk.[6] Lean mass in your arms and legs, adjusted for your height, is how a DEXA scan measures muscle.[7] The scan also estimates visceral fat, and that estimate agrees closely with CT, the reference standard.[12]

Other methods each miss something.

MethodWhat it showsWhat it misses
BMIYour weight relative to your heightMuscle versus fat, and where fat is stored
Waist measurementWhether you likely carry extra fat around your middleHow much of it is visceral, and changes in muscle
Smart scaleAn estimate of body fatVisceral fat. In one hospital study, three popular models underestimated body fat by a median of 2 to 4 kilograms.[13]
DEXA scanFat, muscle, and bone by region, plus visceral fatContext, which takes a physician reading it with your bloodwork

Why is visceral fat the number to watch?

Most of your body fat sits just under the skin. That's subcutaneous fat, the kind you can pinch. Visceral fat sits deeper, wrapped around your liver, intestines, and other organs.

The two don't carry the same risk. An international position statement called excess visceral fat, along with the fat that builds up in organs like the liver, a key driver of heart disease and type 2 diabetes. BMI gives no information about it, so two people with the same BMI can carry very different risk.[3]

In SONATA's analysis of national survey data, adults with a normal BMI and high visceral fat were about three times as likely to be insulin resistant, and the gap held among people of the same age.[4] Insulin resistance means your cells respond less to insulin, so your body has to make more of it to keep blood sugar in range. High visceral fat also clusters at the top of the healthy BMI range. People with a BMI of 23 to 24.9 were about five times as likely to have it as those under 23.[4]

That's one reason a 2025 Lancet commission, endorsed by more than 75 medical organizations, recommended using BMI only as a first screen and confirming body fat with a waist measurement or a direct measure like DEXA.[14]

What's a good visceral fat number?

Scanners report visceral fat as a mass, a volume, or an area, and each brand calibrates differently.[15] At SONATA, we report it in grams from a GE iDXA, the same scanner UK Biobank uses for its imaging study.[16] The numbers below come from GE scanners.

There's no official cutoff yet. The International Society for Clinical Densitometry, the main professional body for DEXA, describes the clinical use of visceral fat measurements as still uncertain.[7] The pattern is consistent, though. In SONATA's analysis, insulin resistance rose with every step up in visceral fat, with no single point where risk suddenly jumped.[4]

Studies on GE scanners help put a number on it. In a New Zealand study of about 1,500 adults, visceral fat above roughly 700 to 800 grams in women and 1,000 to 1,200 grams in men, depending on age, came with two to three times the risk of low HDL cholesterol, high triglycerides, and high blood pressure.[8] Healthy adults in their 20s averaged about 540 grams in men and 260 grams in women.[17]

Our target at SONATA is under 500 grams. That's below the risk cutoffs in these studies for both men and women, and close to where healthy young adults land.

How does visceral fat change in your 30s and 40s?

Visceral fat builds with age, and it builds earlier in men. In SONATA's analysis of adults with a normal BMI, high visceral fat was rare in people in their 20s. Among men, it reached about 1 in 14 in their 30s, 1 in 5 in their 40s, and 1 in 3 in their 50s. Among women, it was about 1 in 20 in their 40s and 1 in 7 in their 50s.[4]

For women, the shift often comes with the menopause transition, which can start as early as 40.[18] In one large study, the rate of fat gain doubled at the start of the transition while lean mass began to decline, and both kept changing until about two years after the final period. Weight didn't speed up at all, so the scale missed it.[19] Another study found visceral fat grew about 8% a year during the transition, faster than aging alone would explain.[20]

A scan in your 30s gives you a baseline to compare against when your body starts to change.

What lowers visceral fat?

Exercise has some of the strongest evidence. A review of 117 studies with nearly 5,000 people found that exercise lowered visceral fat by about 6% even in people who lost no weight, while dieting without weight loss barely moved it. The authors concluded that body weight is a poor way to judge whether a change is working.[5]

Ab exercises build core strength, but in a six-week trial they didn't shrink belly fat or waist size.[9]

Sleep matters too. In a five-year study, adults under 40 who slept five hours or less a night gained more visceral fat than those who slept six to seven hours. It was an observational study, so it can't prove that short sleep caused the gain.[21]

In each case, the scale gives you one number. A scan shows how much of the change was fat, how much was muscle, and where it came from.

How often should you get scanned?

Often enough to see a trend, and far enough apart for real change to show. DEXA measures total fat and lean mass very precisely. On the GE iDXA, total fat varied by less than 1% between scans taken the same day.[11] Visceral fat is harder to pin down. Changes smaller than about 250 grams can be measurement noise, and readings under about 500 grams call for extra caution.[11]

So scan on the same machine each time, since different brands give different numbers for the same person.[6] Keep the conditions the same too, fasted and at the same time of day.[11] Then give a change time to work before you scan again.

Should you get a DEXA scan if you're on a GLP-1?

Yes. About 1 in 8 adults in the US say they're currently taking a GLP-1 drug.[22] The weight loss is real. What a scale can't tell you is what you're losing.

In the main semaglutide trial, people lost about 15% of their body weight. A DEXA substudy of 140 participants found visceral fat fell 27% and total fat 19%, while lean mass fell about 10%.[23] In the main tirzepatide trial, about a quarter of the weight lost was lean mass, a similar split to the placebo group, who had diet and exercise counseling alone.[10] Novo Nordisk and Eli Lilly, the drugs' makers, funded the trials.

Losing some lean mass is a normal part of losing weight. How much it matters is still debated, and researchers have called for studies that measure muscle and strength directly.[24] In the meantime, four lifestyle, nutrition, and obesity medicine societies recommend enough protein and strength training to preserve lean mass.[25]

A scan turns that advice into something you can check. Get a baseline before you start, then scan again as the weight comes off, to see whether you're losing mostly fat and whether your muscle is holding up. The ISCD recommends a body composition scan once weight loss passes about 10%.[7]

It matters after you stop, too. In the semaglutide trial, people regained about two thirds of the weight they'd lost within a year of stopping.[26] A scan shows you what comes back.

Why is a DEXA scan worth more with a physician?

I think everyone in their 30s should know their visceral fat number. It can change for years without showing up on a scale or in a mirror, and it responds to what you do about it.[5, 19]

A number on its own only gets you part of the way. Visceral fat of 800 grams means something different when your bloodwork is clean than when your insulin and triglycerides are starting to rise. The scan tells you where to look. Your bloodwork tells you what it's already doing.

At SONATA, DEXA scans are part of membership, as often as every three months. We run our own GE iDXA in New York, and it's open to our members. Our physicians read each scan alongside your blood pressure and baseline bloodwork, including fasting insulin and HOMA-IR, a measure of insulin resistance, plus triglycerides, HDL, and liver enzymes. When those are shifting too, we act sooner. Then we follow the results scan to scan, so you can see visceral fat come down and muscle hold, even when the scale barely moves.

A scan shows you where you stand. A physician who knows the rest of your health, and follows it with you, turns it into a plan.

Frequently asked questions

Methodology

Figures described as SONATA's analysis come from Harveen Kaur, MD's analysis of NHANES 2011 to 2018, which defines high visceral fat as 100 cm² or more on the Hologic scanners NHANES used. Her post covers the full methods. Visceral fat thresholds in grams come from published studies on GE scanners, since SONATA scans on a GE iDXA and brands calibrate differently. We cite primary studies where we could access them, name the evidence type, and note industry funding.

References

  1. Health Physics Society, Ask the Experts, DEXA radiation dose.
  2. Future and BodySpec announcement, Oct 13, 2026.
  3. Neeland IJ et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease. Lancet Diabetes Endocrinol. 2019.
  4. Kaur H. Can You Have High Visceral Fat With a Normal BMI? SONATA analysis of NHANES 2011–2018.
  5. Verheggen RJ et al. A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev. 2016;17(8):664–690.
  6. NCCOR Measures Registry User Guide, Assessing adiposity, DXA.
  7. ISCD 2023 Adult Official Positions, body composition.
  8. Meredith-Jones K et al. Age- and sex-specific visceral fat reference cutoffs and their association with cardio-metabolic risk. Int J Obes. 2021;45(4):808–817.
  9. Vispute SS et al. The effect of abdominal exercise on abdominal fat. J Strength Cond Res. 2011;25(9):2559–2564.
  10. Look M et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025. Main trial: Jastreboff AM et al. N Engl J Med. 2022;387:205–216.
  11. Dordevic AL et al. Reliability of compartmental body composition measures in weight-stable adults using GE iDXA: implications for research and practice. Nutrients. 2018;10(10):1484.
  12. Kaul S et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity. 2012;20(6):1313–1318.
  13. Frija-Masson J et al. Accuracy of smart scales on weight and body composition. JMIR mHealth uHealth. 2021;9(4):e22487.
  14. Rubino F et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221–262. KCL release.
  15. Bennett JP et al. Visceral adipose tissue reference data computed for GE HealthCare DXA from the NHANES data set. Obesity. 2023;31(12):2947–2959.
  16. UK Biobank, Imaging data (whole-body DXA on GE-Lunar iDXA).
  17. Miazgowski T et al. Visceral fat reference values derived from healthy European men and women aged 20–30 years using GE Healthcare DXA. PLoS One. 2017;12(7):e0180614.
  18. MedlinePlus Magazine (NIH). Menopause: what you need to know. Sept 7, 2023.
  19. Greendale GA et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865.
  20. Samargandy S et al. Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN Heart study. Menopause. 2021. Summary.
  21. Hairston KG et al. Sleep duration and five-year abdominal fat accumulation in a minority cohort: the IRAS Family Study. Sleep. 2010;33(3):289–295. AASM release.
  22. KFF. Public views on prescription drug costs, regulation, affordability, and TrumpRx. Fielded Feb 24 to Mar 2, 2026; published Mar 13, 2026.
  23. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. DXA substudy summary.
  24. Conte C, Hall KD, Klein S. Is weight loss–induced muscle mass loss clinically relevant? JAMA. 2024. Reply: Evans WJ, Cummings S. JAMA. 2024;332(16).
  25. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from ACLM, ASN, OMA, and TOS. May 30, 2025.
  26. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022.
  27. RadiologyInfo.org (RSNA and ACR). Bone densitometry (DEXA, DXA). Last reviewed Mar 11, 2024.

Ready to get started?

Join Now